A New Tool for the Paediatric HIV Research: General Data from the Cohort of the Spanish Paediatric HIV Network (CoRISpe)

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Specialty Infectious Diseases

Date 2013 Jan 4

PMID 23282073

Citations 20

Authors

Ma Isabel De Jose

Santiago Jimenez de Ory

Maria Espiau

Claudia Fortuny

Ma Luisa Navarro

Pere Soler-Palacin

MA Angeles Munoz-Fernandez

Affiliations

Soon will be listed here.

Abstract

There are approximately from 1,100 to 1,200 HIV-infected children in a follow-up in Spain. In 2008 an open, multicentral, retrospective and prospective Cohort of the Spanish Paediatric HIV Network (CoRISpe) was founded. The CoRISpe is divided into the node 1 and node 2 representing geographically almost the whole territory of Spain. Since 2008 seventy-five hospitals have been participating in the CoRISpe. All the retrospective data of the HIV-infected children have been kept in the CoRISpe since 1995 and prospective data since 2008. In this article we are going to present the notion of CoRISpe, its role, the structure, how the CoRISpe works and the process how a child is transferred from Paediatric to Adults Units. The main objective of the CoRISpe is to contribute to furthering scientific knowledge on paediatric HIV infection by providing demographic, sociopsychological, clinical and laboratory data from HIV-infected paediatric patients. Its aim is to enable high-quality research studies on HIV-infected children.

Citing Articles

The Association of HIV-1 Neutralization in Aviremic Children and Adults with Time to ART Initiation and CD4+/CD8+ Ratios.

Sanchez-Merino V, Martin-Serrano M, Beltran M, Lazaro-Martin B, Cervantes E, Oltra M Vaccines (Basel). 2024; 12(1).

PMID: 38276667 PMC: 10820134. DOI: 10.3390/vaccines12010008.

Mental Health in Children, Adolescents, and Youths Living with Perinatally Acquired HIV: At the Crossroads of Psychosocial Determinants of Health.

Vazquez-Perez A, Velo C, Escosa L, Garcia-Lopez T, Bernardino J, Valencia E Children (Basel). 2023; 10(2).

PMID: 36832534 PMC: 9955089. DOI: 10.3390/children10020405.

Transient Viral Rebound in Children with Perinatally Acquired HIV-1 Induces a Unique Soluble Immunometabolic Signature Associated with Decreased CD4/CD8 Ratio.

Tarancon-Diez L, Peraire J, Jimenez de Ory S, Guirro M, Escosa L, Prieto Tato L J Pediatric Infect Dis Soc. 2023; 12(3):143-151.

PMID: 36727571 PMC: 10112677. DOI: 10.1093/jpids/piad008.

Innate and adaptive abnormalities in youth with vertically acquired HIV through a multicentre cohort in Spain.

Carrasco I, Tarancon-Diez L, Vazquez-Alejo E, Jimenez de Ory S, Sainz T, Apilanez M J Int AIDS Soc. 2021; 24(10):e25804.

PMID: 34672108 PMC: 8528666. DOI: 10.1002/jia2.25804.

Effects of perinatal HIV-infection on the cortical thickness and subcortical gray matter volumes in young adulthood.

Ruiz-Saez B, Garcia M, Martinez de Aragon A, Gil-Correa M, Melero H, Malpica N Medicine (Baltimore). 2021; 100(15):e25403.

PMID: 33847637 PMC: 8051971. DOI: 10.1097/MD.0000000000025403.

References

. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA). AIDS. 1998; 12(4):F1-8. View

Ramos J, de Jose M, Polo R, Fortuny C, Mellado M, Munoz-Fernandez M . [Recommendations of the CEVIHP/SEIP/AEP/PNS on antiretroviral treatment in HIV-infected children and teenagers]. Enferm Infecc Microbiol Clin. 2005; 23(5):279-312. DOI: 10.1157/13074970. View

Genebat M, Ruiz-Mateos E, Leon J, Gonzalez-Serna A, Pulido I, Rivas I . Correlation between the Trofile test and virological response to a short-term maraviroc exposure in HIV-infected patients. J Antimicrob Chemother. 2009; 64(4):845-9. DOI: 10.1093/jac/dkp293. View

Palladino C, Briz V, Policarpo S, Silveira L, de Jose M, Gonzalez-Tome M . Long-term efficacy and safety of fosamprenavir in human immunodeficiency virus-infected pediatric patients. Pediatr Infect Dis J. 2010; 29(6):563-6. DOI: 10.1097/INF.0b013e3181d285ac. View

Babiker A, Castro nee Green H, Compagnucci A, Fiscus S, Giaquinto C, Gibb D . First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial. Lancet Infect Dis. 2011; 11(4):273-83. PMC: 3111069. DOI: 10.1016/S1473-3099(10)70313-3. View

Cambon-Thomsen A, Thorisson G, Mabile L . The role of a bioresource research impact factor as an incentive to share human bioresources. Nat Genet. 2011; 43(6):503-4. DOI: 10.1038/ng.831. View

Lotstein D, McPherson M, Strickland B, Newacheck P . Transition planning for youth with special health care needs: results from the National Survey of Children with Special Health Care Needs. Pediatrics. 2005; 115(6):1562-8. DOI: 10.1542/peds.2004-1262. View

Freed G, Hudson E . Transitioning children with chronic diseases to adult care: current knowledge, practices, and directions. J Pediatr. 2006; 148(6):824-7. DOI: 10.1016/j.jpeds.2006.02.010. View

Vigano A, Bedogni G, Manfredini V, Giacomet V, Cerini C, Di Nello F . Long-term renal safety of tenofovir disoproxil fumarate in vertically HIV-infected children, adolescents and young adults: a 60-month follow-up study. Clin Drug Investig. 2011; 31(6):407-15. DOI: 10.2165/11590400-000000000-00000. View

10.

Rosen D, Blum R, Britto M, Sawyer S, Siegel D . Transition to adult health care for adolescents and young adults with chronic conditions: position paper of the Society for Adolescent Medicine. J Adolesc Health. 2003; 33(4):309-11. DOI: 10.1016/s1054-139x(03)00208-8. View

11.

Maturo D, Powell A, Major-Wilson H, Sanchez K, De Santis J, Friedman L . Development of a protocol for transitioning adolescents with HIV infection to adult care. J Pediatr Health Care. 2010; 25(1):16-23. DOI: 10.1016/j.pedhc.2009.12.005. View

12.

de Mulder M, Yebra G, Martin L, Prieto L, Mellado M, Rojo P . Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain. J Antimicrob Chemother. 2011; 66(10):2362-71. DOI: 10.1093/jac/dkr305. View

13.

Noguera-Julian A, Provens A, Soler-Palacin P, Espiau M, Mur A, Mendez M . Pandemic influenza a (2009 H1N1) in human immunodeficiency virus-infected catalan children. Pediatr Infect Dis J. 2010; 30(2):173-5. DOI: 10.1097/INF.0b013e3181f5358b. View

14.

Palladino C, Climent F, de Jose M, Jimenez de Ory S, Bellon J, Guillen S . Causes of death in pediatric patients vertically infected by the human immunodeficiency virus type 1 in Madrid, Spain, from 1982 to mid-2009. Pediatr Infect Dis J. 2011; 30(6):495-500. DOI: 10.1097/INF.0b013e318211399f. View

15.

Resino S, Micheloud D, Lorente R, Bellon J, Navarro M, Munoz-Fernandez M . Adipokine profiles and lipodystrophy in HIV-infected children during the first 4 years on highly active antiretroviral therapy. HIV Med. 2010; 12(1):54-60. DOI: 10.1111/j.1468-1293.2010.00837.x. View

16.

Garcia-Merino I, de Las Cuevas N, Jimenez J, Garcia A, Gallego J, Gomez C . Pediatric HIV BioBank: a new role of the Spanish HIV BioBank in pediatric HIV research. AIDS Res Hum Retroviruses. 2010; 26(2):241-4. DOI: 10.1089/aid.2009.0122. View

17.

Gurbindo D, Resino S, Sanchez-Ramon S, Leon J, Munoz-Fernandez M . Correlation of viral load and CD8 T-lymphocytes with development of neurological manifestations in vertically HIV-1-infected infants. A prospective longitudinal study. Neuropediatrics. 1999; 30(4):197-204. DOI: 10.1055/s-2007-973490. View

18.

Por J, Golberg B, Lennox V, Burr P, Barrow J, Dennard L . Transition of care: health care professionals' view. J Nurs Manag. 2004; 12(5):354-61. DOI: 10.1111/j.1365-2834.2004.00428.x. View

19.

. Children born to women with HIV-1 infection: natural history and risk of transmission. European Collaborative Study. Lancet. 1991; 337(8736):253-60. View

20.

. Transitioning to adult health care facilities for young adults with a chronic condition. Pediatr Nurs. 2002; 27(5):521-4. View